Stratifying Risk and Treatment Benefit: A Model Predicting Overall Survival in Men with Metastatic De Novo Hormone-sensitive Prostate Cancer in Trials Investigating Docetaxel (the STOPCAP Collaboration)
风险分层和治疗获益：预测多西他赛治疗试验中转移性新发激素敏感性前列腺癌男性患者总生存期的模型（STOPCAP 合作组）
期刊:European Urology Focus
影响因子:5.6
doi:10.1016/j.euf.2026.02.001
Halabi, Susan; Luo, Bin; Yu, Chenxi; Rydzewska, Larysa H M; Roy, Akash; Kim, Hyotae; Godolphin, Peter J; Murphy, Laura; Carducci, Michael A; Gravis, Gwenaëlle; Sfumato, Patrick; Boher, Jean-Marie; James, Nicholas D; Tierney, Jayne F; Page, David; Sweeney, Christopher; Guo, Siyuan
